NAD+ Oral Supplement Pilot Intervention in Adult Females

Launched by UNIVERSITY OF RHODE ISLAND · Aug 28, 2024

Keywords

ClinConnect Summary

This clinical trial is looking into whether a supplement called Nicotinamide adenine dinucleotide (NAD+) can help improve thinking skills and reduce inflammation in healthy Latina women aged 40 to 80. The researchers want to find out if taking NAD+ for four weeks can lead to better executive function, which is a type of thinking that helps with planning and decision-making, and if it can lower certain markers in the blood that indicate inflammation and brain health.

To participate in this study, women must identify as Latina, have experienced three or more difficult situations during childhood, and have a body mass index (BMI) of 18.5 or higher. Those who are on hormone medications, pregnant, or breastfeeding cannot join. Participants will fill out an online questionnaire, visit the lab for brain tests and blood samples, and take either the NAD+ supplement or a placebo (a non-active pill) every day for four weeks. This study is currently recruiting participants, and it offers a chance to contribute to important research about cognitive health in women.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Identify as Latina, have three or more adverse childhood experiences, and a BMI of 18.5 or above
• Exclusion Criteria:
• • Those who are taking hormone medication, pregnant or breastfeeding